Mesothelioma

Researchers have developed an innovative mesothelioma testing strategy that could potentially increase the detection rate of cancer DNA in the blood.

Dr. Travis Grotz explains how hyperthermic intraperitoneal chemotherapy works and how it can help patients with certain late-stage cancers.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.